Adipotide (FTTP) Peptide: Research in Targeted Adipose Tissue Vasculature
May 8, 2026 Adipotide, also known as FTTP (Fat Targeted Pro-apoptotic Peptide), is an experimental peptidomimetic research agent designed to target and eliminate white adipose tissue. Research indicates that Adipotide operates through a unique mechanism…
AOD9604 Peptide: Research in Lipolysis and Cartilage Regeneration
May 8, 2026 AOD9604 (Advanced Obesity Drug) is a synthetic peptide fragment derived from the C-terminal end of human growth hormone (hGH), specifically encompassing amino acids 177-191 with an added tyrosine at the N-terminal to stabilize the molecule.…
CJC-1295 with DAC: Research in Sustained Growth Hormone Stimulation
May 11, 2026 CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of the endogenous Growth Hormone-Releasing Hormone (GHRH). Research indicates that this peptide is a potent growth hormone secretagogue, specifically engineered to extend the…
Dulaglutide Peptide: Research in Metabolic Regulation and GLP-1 Agonism
May 13, 2026 Dulaglutide is a synthetic fusion protein and long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that research indicates is a powerful modulator of metabolic signaling. Unlike native GLP-1, which has an extremely short half-life…